Marcelo O Mangalindan - FDA Investigator Report

Overview Statistics

117
Total Inspections
64
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 29 days
Shortest Inspection: 1 days
Average Length: 5.4 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Marcelo O Mangalindan's Recent Inspections

DateCompanyCityCountryFEI Number483
2018-05-30CLINLOGIX LLCAmblerUnited States3012957356
2018-04-25Margaret A. Keller PhDPhiladelphiaUnited States3014225818
2018-04-16Tris Pharma Inc.Monmouth JunctionUnited States3004712471
2018-03-09Giacomina Massaro-Giordano M.D.PhiladelphiaUnited States3014220789
2017-12-19Pascal M. Jabbour, MDPhiladelphiaUnited States3013723285
2017-11-21Janssen Research & Development, LLCSpring HouseUnited States3005548382
2017-10-27Geert D'HaensAmsterdamNetherlands3013665123
2017-09-27Joel D. Cooper, M.D.PhiladelphiaUnited States3005921257
2017-07-28Yen-Hwa ChangTaipeiTaiwan3013462117
2017-07-21Luigina Mollica, M.D.MontrealCanada3013488844

Sign Up to get the complete report.

Download 483s and EIRs for Marcelo O Mangalindan

Marcelo O Mangalindan - Co-Inspectors

Marcelo O Mangalindan's Active Locations

  • United States
  • Canada
  • France
  • United Kingdom
  • Germany
  • Spain
  • Poland
  • Slovakia
  • Taiwan
  • Netherlands
  • Korea, Republic Of (South)
  • Australia
  • Korea (the Republic of)
  • Italy

Marcelo O Mangalindan's Year-wise Inspection Count

  • 2008:22 inspections
  • 2009:13 inspections
  • 2010:14 inspections
  • 2011:5 inspections
  • 2013:6 inspections
  • 2014:17 inspections
  • 2015:12 inspections
  • 2016:12 inspections
  • 2017:12 inspections
  • 2018:4 inspections
Last Updated: 2025-05-14 06:11:22